Literature DB >> 648029

Complex arming in antibody-dependent cell-mediated cytotoxicity: ultrastructural studies of the interaction between human effector cells armed with aggregated anti-DNP antibody and DNP-coated erythrocytes.

P L Penfold, L C Walker, I M Roitt.   

Abstract

We have examined, by transmission electron microscopy, mixtures of DNP-coated chicken red blood cells and normal human peripheral blood leucocytes 'armed' with alkali-aggregated anti-dinitrophenyl (DNP) antibody. The combination of these observations with chromium release assays enabled us to identify four types of effector cell interacting with the target erythrocytes, viz. phagocytic and non-phagocytic monocytes, neutrophils and lymphocytes. Comparison of these findings with previous work, using antibody-coated targets, allowed us to conclude that the mechanisms and cell types involved are similar. We also demonstrated the short-lived cytotoxic potential of cells armed in this manner.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 648029      PMCID: PMC1541223     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  23 in total

1.  Characteristics of the effector cells mediating cytotoxicity against antibody-coated target cells. II. The mouse nonadherent K cell.

Authors:  A H Greenberg; L Shen; L Walker; A Arnaiz-Villena; I M Roitt
Journal:  Eur J Immunol       Date:  1976-07       Impact factor: 5.532

2.  Cytological observations on the cytotoxic interaction between lymphocytes and antibody-coated monolayer cells.

Authors:  P Biberfeld; G Biberfeld; P Perlmann; G Holm
Journal:  Cell Immunol       Date:  1973-04       Impact factor: 4.868

3.  A class of specific cytotoxic cells demonstrated in vitro by arming with antigen-antibody complexes.

Authors:  A H Greenberg; L Shen
Journal:  Nat New Biol       Date:  1973-10-31

4.  The role of immunoglobulins in lymphocyte-mediated cell damage, in vitro. I. Comparison of the effects of target cell specific antibody and normal serum factors on cellular damage by immune and non-immune lymphocytes.

Authors:  I C MacLennan; G Loewi; B Harding
Journal:  Immunology       Date:  1970-03       Impact factor: 7.397

5.  Lymphocyte cytotoxicity induced by pre-incubation with serum from patients with Hashimoto thyroiditis.

Authors:  E A Calder; D McLeman; W J Irvine
Journal:  Clin Exp Immunol       Date:  1973-11       Impact factor: 4.330

6.  Antibody-dependent human lymphocytotoxicity: a micro assay system.

Authors:  W P Zeijlemaker; M T Roos; P T Schellekens; V P Eijsvoogel
Journal:  Eur J Immunol       Date:  1975-08       Impact factor: 5.532

7.  Electron microscopic studies of human monocyte and lymphocyte interaction with immunoglobulin- and complement-coated erythrocytes.

Authors:  S D Douglas; H Huber
Journal:  Exp Cell Res       Date:  1972-01       Impact factor: 3.905

8.  Two types of antibody dependent cell-mediated cytotoxicity, arming and sensitization.

Authors:  T Imir; E Saksela; O Mäkelä
Journal:  J Immunol       Date:  1976-11       Impact factor: 5.422

9.  Differentiation of monocytes. Origin, nature, and fate of their azurophil granules.

Authors:  B A Nichols; D F Bainton; M G Farquhar
Journal:  J Cell Biol       Date:  1971-08       Impact factor: 10.539

10.  Studies of the human lymphocyte receptor for heat-aggregated or antigen-complexed immunoglobulin.

Authors:  H B Dickler
Journal:  J Exp Med       Date:  1974-08-01       Impact factor: 14.307

View more
  3 in total

1.  Approach to the radiosensitivity of antibody dependent cellular cytotoxicity.

Authors:  D Dormont; B Coupez; F Herodin; N Delasnerie-Laupretre; A Bohu; C Pasquier
Journal:  Br J Cancer Suppl       Date:  1986

2.  Characteristics of complexes for arming and inhibiting effector cells for antibody-dependent cell-mediated cytotoxicity.

Authors:  L Walker; F C Hay; I M Roitt
Journal:  Clin Exp Immunol       Date:  1979-06       Impact factor: 4.330

3.  Multiple antibodies targeting tumor-specific mutations redirect immune cells to inhibit tumor growth and increase survival in experimental animal models.

Authors:  G S Shukla; S C Pero; Y -J Sun; L Mei; F Zhang; G Sholler; D N Krag
Journal:  Clin Transl Oncol       Date:  2019-11-16       Impact factor: 3.405

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.